STAT6 and asthma: Against this backdrop, and given the mainstay of asthma therapy continues to rely on the use of inhaled steroids [10], which can have undesired side effects [11], we have developed a more refined therapeutic approach that harnesses the endogenous RNA-interference mechanism to specifically suppress STAT6 expression in epithelial cells using small interfering RNA (siRNA) [12, 13].